These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 38991254)
1. PFKL promotes cell viability and glycolysis and inhibits cisplatin chemosensitivity of laryngeal squamous cell carcinoma. Wang P; Ye Y; Chen Z; Li R; Hou G; Liu Z Biochem Biophys Res Commun; 2024 Oct; 730():150366. PubMed ID: 38991254 [TBL] [Abstract][Full Text] [Related]
2. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma. Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371 [TBL] [Abstract][Full Text] [Related]
3. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway. Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130 [TBL] [Abstract][Full Text] [Related]
4. Exosomes from M2 macrophages promoted glycolysis in FaDu cells by inhibiting PDLIM2 expression to stabilize PFKL. Wang P; Li GY; Zhou L; Jiang HL; Yang Y; Wu HT Neoplasma; 2022 Sep; 69(5):1041-1053. PubMed ID: 35723199 [TBL] [Abstract][Full Text] [Related]
5. Curcumin suppresses the malignant phenotype of laryngeal squamous cell carcinoma through downregulating E2F1 to inhibit FLNA. Xie Y; Qi J; Liu J Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep; 397(9):6929-6939. PubMed ID: 38592439 [TBL] [Abstract][Full Text] [Related]
6. The Anti-tumor Activity and Mechanisms of rLj-RGD3 on Human Laryngeal Squamous Carcinoma Hep2 Cells. Jin Y; Lv L; Ning SX; Wang JH; Xiao R Anticancer Agents Med Chem; 2019; 19(17):2108-2119. PubMed ID: 31642792 [TBL] [Abstract][Full Text] [Related]
7. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p. Zheng Y; Duan L; Yang Y; Luo D; Yan B Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of ALDH5A1 suppresses cisplatin resistance in esophageal squamous cell carcinoma by regulating ferroptosis signaling pathways. Song K; Ma C; Maswikiti EP; Gu B; Wang B; Wang N; Jiang P; Chen H Mol Carcinog; 2024 Oct; 63(10):1892-1906. PubMed ID: 38923019 [TBL] [Abstract][Full Text] [Related]
9. E2F1-Induced FTH1P3 Promoted Cell Viability and Glycolysis Through miR-377-3p/LDHA Axis in Laryngeal Squamous Cell Carcinoma. Zhao L; Zheng Y; Zhang L; Su L Cancer Biother Radiopharm; 2022 May; 37(4):276-286. PubMed ID: 33571038 [No Abstract] [Full Text] [Related]
10. Farrerol suppresses the progression of laryngeal squamous cell carcinoma via the mitochondria-mediated pathway. Zhang T; Liu H; Liu M; Wang C Eur J Pharmacol; 2021 Dec; 913():174636. PubMed ID: 34801529 [TBL] [Abstract][Full Text] [Related]
11. tRNA Li J; Shen Z; Luo L; Ye D; Deng H; Gu S; Zhou C J Clin Lab Anal; 2021 Jul; 35(7):e23821. PubMed ID: 34048096 [TBL] [Abstract][Full Text] [Related]
12. Circular RNA circCORO1C promotes laryngeal squamous cell carcinoma progression by modulating the let-7c-5p/PBX3 axis. Wu Y; Zhang Y; Zheng X; Dai F; Lu Y; Dai L; Niu M; Guo H; Li W; Xue X; Bo Y; Guo Y; Qin J; Qin Y; Liu H; Zhang Y; Yang T; Li L; Zhang L; Hou R; Wen S; An C; Li H; Xu W; Gao W Mol Cancer; 2020 Jun; 19(1):99. PubMed ID: 32487167 [TBL] [Abstract][Full Text] [Related]
13. Ribophorin II promotes the epithelial-mesenchymal transition and aerobic glycolysis of laryngeal squamous cell carcinoma via regulating reactive oxygen species-mediated Phosphatidylinositol-3-Kinase/Protein Kinase B activation. Zhou J; Zhang J; Zhang W; Ke Z; Lv Y; Zhang B; Liao Z Bioengineered; 2022 Mar; 13(3):5141-5151. PubMed ID: 35156537 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of circRNA_100290 promotes the progression of laryngeal squamous cell carcinoma through the miR-136-5p/RAP2C axis. Wang Z; Huang C; Zhang A; Lu C; Liu L Biomed Pharmacother; 2020 May; 125():109874. PubMed ID: 32014687 [TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation-mediated downregulation of the LINC01554 gene accelerates the malignant progression and regulates the chemosensitivity of laryngeal squamous cell carcinoma. Wang J; Meng W; Yang J; Cao H; Liu T; Yang C; Yu M; Wang B J Physiol Pharmacol; 2022 Apr; 73(2):. PubMed ID: 35988928 [TBL] [Abstract][Full Text] [Related]
16. CircPRRC2C Promotes the Oncogenic Phenotypes of Laryngeal Squamous Cell Carcinoma Cells via MiR-136-5p/HOXD11 Axis. Peng X; Chen X; Peng S; Chen Y; Li Y; Tian Y Mol Biotechnol; 2024 Sep; 66(9):2381-2395. PubMed ID: 37728841 [TBL] [Abstract][Full Text] [Related]
17. Non-canonical RNA-binding protein ANXA11 regulates microRNA resorting into small extracellular vesicles to mediate cisplatin resistance. Zhang Y; Huang Q; Shen Y; Ren H; Wu C; Zhou L FASEB J; 2024 Sep; 38(17):e70048. PubMed ID: 39259536 [TBL] [Abstract][Full Text] [Related]
18. The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/β-catenin pathway. Kang R; Yao DF; Xu GZ; Zhou YH Neoplasma; 2020 Sep; 67(5):1094-1105. PubMed ID: 32538668 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia-induced ROS promotes mitochondrial fission and cisplatin chemosensitivity via HIF-1α/Mff regulation in head and neck squamous cell carcinoma. Wu K; Mao YY; Chen Q; Zhang B; Zhang S; Wu HJ; Li Y Cell Oncol (Dordr); 2021 Oct; 44(5):1167-1181. PubMed ID: 34460078 [TBL] [Abstract][Full Text] [Related]
20. TGF-β-induced long non-coding RNA MIR155HG promotes the progression and EMT of laryngeal squamous cell carcinoma by regulating the miR-155-5p/SOX10 axis. Cui W; Meng W; Zhao L; Cao H; Chi W; Wang B Int J Oncol; 2019 Jun; 54(6):2005-2018. PubMed ID: 31081043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]